Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short term Debt (2018 - 2021)

Historic Short term Debt for AC Immune (ACIU) over the last 3 years, with Q3 2020 value amounting to $336773.3.

  • AC Immune's Short term Debt fell 65.5% to $336773.3 in Q3 2020 from the same period last year, while for Sep 2020 it was $336773.3, marking a year-over-year decrease of 65.5%. This contributed to the annual value of $656409.3 for FY2019, which is 9332.29% up from last year.
  • Per AC Immune's latest filing, its Short term Debt stood at $336773.3 for Q3 2020, which was down 65.5% from $333137.6 recorded in Q2 2020.
  • AC Immune's Short term Debt's 5-year high stood at $658770.1 during Q4 2019, with a 5-year trough of $333137.6 in Q2 2020.
  • Its 3-year average for Short term Debt is $389374.4, with a median of $335869.8 in 2020.
  • As far as peak fluctuations go, AC Immune's Short term Debt skyrocketed by 9747.0% in 2019, and later tumbled by 65.5% in 2020.
  • AC Immune's Short term Debt (Quarter) stood at $333605.1 in 2018, then soared by 97.47% to $658770.1 in 2019, then plummeted by 48.88% to $336773.3 in 2020.
  • Its Short term Debt stands at $336773.3 for Q3 2020, versus $333137.6 for Q2 2020 and $334966.3 for Q1 2020.